FEATURED/ARCHIVES (20/05/24)
Efficacy of Brexpiprazole for Treatment Persistent Negative Symptoms in Three Schizophrenic Patients: A Case Series · August 2022
Articles
Psychiatry Research Case Reports
Profile of Paliperidone Palmitate Once-Monthly Long-Acting Injectable in the Management of Schizophrenia: Long-Term Safety, Efficacy, and Patient Acceptability- A Review · May 2015
Articles
Patient Preference and Adherence
A Naturalistic Comparison Study of the Efficacy and Safety of Intramuscular Olanzapine, Intramuscular Haloperidol, and Intramuscular Levomepromazine in Acute Agitated Patients with Schizophrenia · January 2014
Abstracts
Human Psychopharmacology: Clinical and Experimental
Efficacy and Safety of Anti-Inflammatory Agents in Treatment of Psychotic Disorders: A Comprehensive Systematic Review and Meta-Analysis · September 2020
Abstracts
Brain, Behavior, and Immunity
Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients with Acute Exacerbation of Schizophrenia · April 2010
Abstracts
Journal of Clinical Psychopharmacology
Aripiprazole Lauroxil 2-Month Formulation with 1-Day Initiation for Acute Schizophrenia: ALPINE Exploratory Efficacy and Patient-Reported Outcomes · May 2021
Abstracts
CNS Spectrums
Efficacy and Acceptability of Cariprazine in Acute Exacerbation of Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials · February 2018
Abstracts
Journal of Clinical Psychopharmacology
Efficacy of Zinc Sulfate as an Add-On Therapy to Risperidone versus Risperidone Alone in Patients with Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial · September 2015
Articles
Iranian Journal of Psychiatry and Behavioral Sciences
Efficacy and Safety of Lurasidone 80 Mg/Day and 160 Mg/Day in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Active-Controlled Trial · April 2013
Articles
Schizophrenia Research
Safety and Efficacy of Paliperidone Extended-Release in Chinese Patients with Schizophrenia: A 24-Week, Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study · January 2016
Articles
Neuropsychiatric Disease and Treatment
A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia · January 2013
Articles
Psychiatry and Clinical Psychopharmacology
Efficacy and Tolerability of Paliperidone ER in Patients with Unsatisfactorily Controlled Schizophrenia by Other Antipsychotics: A Flexible-Dose Approach · November 2015
Articles
International Clinical Psychopharmacology
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis · September 2018
Articles
Frontiers in Pharmacology
Case Report: Cariprazine Efficacy in Young Patients Diagnosed with Schizophrenia with Predominantly Negative Symptoms · November 2021
Articles
Frontiers in Psychiatry
A Commentary on the Efficacy of Olanzapine for the Treatment of Schizophrenia: The Past, Present, and Future · September 2019
Articles
Neuropsychiatric Disease and Treatment
Randomized, Placebo-Controlled, Double-Blind Study Assessing the Efficacy and Safety of Paliperidone Palmitate in Asian Patients with Schizophrenia · December 2013
Articles
Neuropsychiatric Disease and Treatment
Efficacy of Lurasidone in Patients with Schizophrenia with Prominent Positive Symptoms: A Pooled Analysis of Short-Term Placebo-Controlled Studies (Meetings-Events) · June 2016
Abstracts
International Journal of Neuropsychopharmacology
Long-Term Safety and Efficacy of Olanzapine Long-Acting Injection in Patients with Schizophrenia or Schizoaffective Disorder: A 6-Year, Multinational, Single-Arm, Open-Label Study · November 2014
Articles
International Clinical Psychopharmacology
Efficacy of Community Treatments for Schizophrenia and Other Psychotic Disorders: A Literature Review · October 2013
Articles
Frontiers in Psychiatry
Efficacy of Antidepressants in Treating the Negative Symptoms of Chronic Schizophrenia: Meta-Analysis · September 2010
Articles
British Journal of Psychiatry